Akash Singh

Dr. Akash Singh


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 May 2024 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
Shaban AhmadShaban Ahmad
Shaban Ahmad
ASAkash Singh
Akash Singh
NBNAGMI BANO
NAGMI BANO
KRKhalid Raza
Khalid Raza
JSJanmejay Singh
Janmejay Singh
HGHemant Kumar Gautam
Hemant Kumar Gautam

7 August 2023 in Journal of Biomolecular Structure and Dynamics
Verified
Journal Article
Closed access
ASAkash Singh
Akash Singh
Shaban AhmadShaban Ahmad
Shaban Ahmad
KRKhalid Raza
Khalid Raza
HGHemant Kumar Gautam
Hemant Kumar Gautam
Cutibacterium acnes is an opportunistic pathogen linked with acne vulgaris, affecting 80-90% of teenagers globally. On the leukocyte (WBCs) cell surface, the cell wall anchored sialidase in C. acnes virulence factor, catalysing the sialoconjugates into sialic acids and nutrients for C. acnes resulting in human skin inflammation. The clinical use of antibiotics for acne treatments has severe adverse effects, including microbial dysbiosis and resistance. Therefore, identifying inhibitors for primary virulence factors (Sialidase) was done using molecular docking of 1030 FDA-approved drugs. Initially, based on binding energies (ΔG), Naloxone (ZINC000000389747), Fenoldopam (ZINC000022116608), Labetalol (ZINC000000403010) and Thalitone (ZINC000000057255) were identified that showed high binding energies as -10.2, -10.1, -9.9 and -9.8 kcal/mol, respectively. In 2D analysis, these drugs also showed considerable structural conformer of hydrogen and hydrophobic interactions. Further, a 100 ns MD simulation study found the lowest deviation and fluctuations with various intermolecular interactions to stabilise the complexes. Out of 4, the Naloxone molecule showed robust, steady, and stable RMSD 0.23 ± 0.18 nm. Further, MMGBSA analysis supports MD results and found strong binding energy (ΔG) -29.71 ± 4.97 kcal/mol. In Comparative studies with Neu5Ac2en (native substrate) revealed naloxone has a higher affinity for sialidase. The PCA analysis showed that Naloxone and Thalitone were actively located on the active site, and other compounds were flickered. Our extensive computational and statistical report demonstrates that these FDA drugs can be validated as potential sialidase inhibitors.Communicated by Ramaswamy H. Sarma.

Verified
Journal Article
Open access
PDF file
ASAkash Singh
Akash Singh
Shaban AhmadShaban Ahmad
Shaban Ahmad
ARAhona Roy
Ahona Roy
KRKhalid Raza
Khalid Raza
HGHemant Kumar Gautam
Hemant Kumar Gautam
Chronic diseases such as diabetes and cancer are the leading causes of mortality worldwide. Receptors for Advanced Glycation End products (RAGEs) are ubiquitous factors that catalyse Advanced Glycation End products (AGEs), proteins, and lipids that become glycated from sugar ingestion. RAGEs are cell surface receptor proteins and play a broad role in mediating the effects of AGEs on cells, contributing to modifying biological macromolecules like proteins and lipids, which can cause Reactive Oxygen Species (ROS) generation, inflammation, and cancer. We targeted RAGE inhibition analysis and screening of United States Food and Drug Administration (FDA) libraries through molecular docking studies that identified the four most suitable FDA compounds: Zytiga, Paliperidone, Targretin, and Irinotecan. We compared them with the control substrate, Carboxymethyllysine, which showed good binding interaction through hydrogen bonding, hydrophobic interactions, and π-stacking at active site residues of the target protein. Following a 100 ns simulation run, the docked complex revealed that the Root Mean Square Deviation (RMSD) values of two drugs, Irinotecan (1.3 ± 0.2 nm) and Paliperidone (1.2 ± 0.3 nm), were relatively stable. Subsequently, the Molecular Mechanics Poisson–Boltzmann Surface Area (MMPBSA) determined that the Paliperidone molecule had a high negative energy of −13.49 kcal/mol, and the Absorption, Distribution, Metabolism, and Excretion (ADME) properties were in control for use in the mentioned cases. We extended this with many in vitro studies, including an immunoblotting assay, which revealed that RAGEs with High Mobility Group Box 1 (HMGB1) showed higher expression, while RAGEs with Paliperidone showed lower expressions. Furthermore, cell proliferation assay and Apoptosis assay (Annexin-V/PI staining) results revealed that Paliperidone was an effective anti-glycation and anti-apoptotic drug—however, more extensive in vivo studies are needed before its use.

3 June 2025 in Journal of Science Innovations and Nature of Earth
Verified
Journal Article
Open access
PDF file
KSKalpana Singh
Kalpana Singh
ASAkash Singh
Akash Singh
BHBhavana
Bhavana
VSVivek Singh
Vivek Singh
Incidences and related mortality are rising for diabetes mellitus, one of the world's leading health issues across the world. Inadequate blood sugar control has detrimental effects on human health. Conventional antidiabetic medications are effective, but they also have unavoidable side effects. Conversely, medicinal plants might serve as a different source of antidiabetic substances. With an emphasis on preclinical and clinical research, examples of therapeutic herbs that may help lower blood sugar levels. The profile of physiologically active chemicals in each plant matrix, their coordinated and combined activity, and the possible advantages are examined.